SXTC

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) is a Chinese pharmaceutical company founded in 2005 and headquartered in Taizhou, China. The company went public on the NASDAQ in January 2019. SXT specializes in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP), operating primarily within China's healthcare market. The company has experienced significant financial volatility in recent years, with fluctuating revenues and alternating periods of profitability and losses.